Already sick, former patients of the failed kidney and liver transplant units face rejection and despair as they look elsewhere and grapple with the one thing they cannot afford to lose: time.
Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...
Aug. 21, 2024 — A research team has shown the benefits of camu-camu on non-alcoholic fatty liver disease. This exotic fruit reduces liver fat ... Liver Transplant Outperforms Other Therapies for ...
The Children’s Hospital of Philadelphia announces that after nearly a year they have successfully separated conjoined twin boys. Amari and Javar Ruffin, who live in Philadelphia, shared the ...